Key Takeaways
- Clinical Bottom Line
- Identifying the Invisible Lesion
Clinical Bottom Line
| Paris Classification | Morphological Feature | Malignant Risk / Endoscopic Management |
|---|---|---|
| Type 0-Ip (Protruded) | Pedunculated or sessile exophytic masses. | Easily identified; curable via simple hot snare polypectomy or EMR. |
| Type 0-IIa / IIb | Slightly elevated (IIa) or completely flat (IIb). | Extremely easy to miss under standard white light; requires dense chromoendoscopy. |
| Type 0-IIc (Depressed) | Slight mucosal depression or excavation. | Highest rate of deep submucosal invasion; almost universally mandates Endoscopic Submucosal Dissection (ESD). |
Identifying the Invisible Lesion
Gastric cancer mortality is intricately linked to the stage at diagnosis. In Japan and South Korea, where rigorous screening programs exist, Gastric Adenocarcinoma is frequently identified in its earliest, superficially confined stages (Early Gastric Cancer, EGC). In these stages, it is completely curable via endoscopic resection, avoiding the profound morbidity of a surgical gastrectomy.
The Paris Matrix
EGC very rarely presents as an obvious, massive bleeding tumor. It manifests as a subtle, flat discoloration (Type 0-IIb) or a slightly depressed mucosal irregularity (Type 0-IIc). The Paris Classification provides the universal morphological language for staging these superficial lesions prior to resection. A “depressed” 0-IIc lesion, despite appearing superficially small, is highly biologically aggressive and notoriously invades deeply into the submucosa, drastically limiting the utility of a standard snare EMR and forcing the endoscopist to execute a complex, time-consuming ESD procedure to secure physically pristine, deep margins.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
